Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.003 Å; disorder in main residue; R factor = 0.047; wR factor = 0.139; data-to-parameter ratio = 21.3.
In the title compound, C 28 H 27 ClN 2 O 3 S, the central imidazolidine ring adopts an envelope conformation with the C atom bearing the chlorophenyl ring at the flap. The geometry around the S atom is distorted tetrahedral. Three methylene groups of the cyclohexene ring are disordered over two sets of sites [site occupancies = 0.562 (10) and 0.438 (10)]. The crystal packing is stabilized by C-HÁ Á Á interactions.
Related literature
For the biological activity of sulfonamides, see: Zareef et al. (2007) ; Chohan & Shad (2008) ; Pomarnacka & Kozlarska-Kedra (2003) ; Nieto et al. (2005) ; Wang et al. (1995) . For a related structure, see: Ranjith et al. (2011) . For puckering parameters, see: Cremer & Pople (1975) . For ring asymmetry parameters, see: Nardelli et al. (1983) .
Experimental
Crystal data 
Data collection
Bruker APEXII CCD area detector diffractometer Absorption correction: multi-scan (SADABS; Sheldrick, 1996) T min = 0.934, T max = 0.950 32488 measured reflections 7366 independent reflections 4844 reflections with I > 2(I) R int = 0.034 Refinement R[F 2 > 2(F 2 )] = 0.047 wR(F 2 ) = 0.139 S = 1.01 7366 reflections 346 parameters 4 restraints H-atom parameters constrained Á max = 0.30 e Å À3 Á min = À0.33 e Å À3 Table 1 Hydrogen-bond geometry (Å , ).
Cg2 and Cg4 are the centroids of the C2-C7 and C15-C20 rings, respectively.
Symmetry code: (i) Àx; Ày þ 1; Àz.
Data collection: APEX2 (Bruker, 2004); cell refinement: SAINT (Bruker, 2004); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997); software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2009). used to control diseases caused by bacterial infections. Benzene sulfonamide derivatives are known to exhibit anticancer and HIV activities (Pomarnacka & Kozlarska-Kedra, 2003) and antibacterial activities (Nieto et al., 2005) . Imidazolidine compounds are important intermediates and building blocks in the construction of various biologically active compounds (Wang et al., 1995) . Against this background, and in order to obtain detailed information on molecular conformations in the solid state, an X-ray study of the title compound was carried out.
X-Ray analysis confirms the molecular structure and atom connectivity as illustrated in Fig. 1 . The geometry around the S atom is distorted tetrahedral, comprising two O atoms of the sulfonyl group, a C atom of a phenyl ring and the imidazolidine N atom. The S-O, S-C, and S-N distances are 1.416 (2), 1.747 (2) and 1.677 (2) Å, respectively, these are comparable as observed in similar structures (Ranjith et al., 2011) . The atom Cl1 is deviated by 0.136 (1)Å from the leastsquares plane of the rings C9-C14. The S atom exhibits significant deviation from that of a regular tetrahedron, with the largest deviations for the O-S-O [O1-S1-O2 121.2 (9)°] and O-S-N angles [O1-S1-N1 106.4 (7)°]. The widening of the angles may be due to repulsive interactions between the two short S=O bonds, similar to what is observed in related structures (Ranjith et al., 2011) .
The imidazolidine ring adopts envelope conformation, with the puckering parameters q 2 and φ (Cremer & Pople, 1975) and the smallest displacement asymmetric parameters,Δ, (Nardelli et al., 1983) as follows: q 2 =0.1230 (17) Å, φ=211.7 (8)°, Δ s (C8)=1.50 (17) and the cyclohexane ring adopts half-chair conformation, in addition to with the puckering parameters q 2 and φ (Cremer & Pople, 1975) and the smallest displacement asymmetric parameters,Δ, (Nardelli et al., 1983) as follows: q 2 =0.399 (7) Å, φ=127.2 (8)°, Δ s (C24)= 18.4 (7). In the crystal, the molecules form layers that are linked by π···π stacking interactions between the imidazolidine and benzene [C9-C14] rings [centroid-centroid distances = 3.7406 (9) Å].
Experimental 4-Toluenesulfonyl azide (1.3 mmol), 1-ethynyl cyclohexene (1.2 mmol), 4-chlorophenyl N-phenylnitrone (1.0 mmol) and triethylamine (2 mmol) were successively added to Cu 1 -Y zeolite (30 mg) in dichloromethane under N 2 atmosphere. After stirring at room temperature for the 6 h, the mixture was diluted with dichloromethane. After removing the catalyst by filtration, followed by solvent evaporation, the resulting crude product was finally purified by column chromatography (silica gel). Single crystals suitable for X-ray diffraction were obtained by slow evaporation of a solution of the title compound in acetone at room temperature. supplementary materials sup-2 Refinement Three methylene groups of the cyclohexane ring are disordered over two positions (C25/C25', C26/C26' and C27/C27') with refined occupancies of 0.562 (10) and 0.438 (10). The corresponding bond distances involving the disordered atoms were restrained to be equal. All H atoms were fixed geometrically and allowed to ride on their parent C atoms, with C-H distances fixed in the range 0.93-0.97 Å with U iso (H) = 1.5U eq (C) for methyl H 1.2U eq (C) for other H atoms. Fig. 1 . The structure of showing the atom-numbering scheme. The displacement ellipsoids are drawn at the 30% probability level. The disordered atoms are omitted for clarity. (2) 0.0324 (9) −0.0009 (13) 0.0133 (9) 0.0025 (11) C8 0.0349 (8) 0.0439 (9) 0.0279 (7) −0.0005 (7) 0.0077 (6) −0.0007 (6) C9 0.0319 (7) 0.0399 (9) 0.0290 (7) 0.0002 (6) 0.0082 (6) 0.0011 (6) C10 0.0420 (9) 0.0409 (9) 0.0345 (8) −0.0053 (7) 0.0091 (7) 0.0022 (7) C11 0.0399 (9) 0.0457 (10) 0.0391 (9) −0.0019 (7) 0.0037 (7) −0.0053 (7) C12 0.0423 (9) 0.0531 (10) 0.0276 (7) 0.0079 (8) 0.0039 (6) 0.0011 (7) C13 0.0529 (10) 0.0473 (10) 0.0382 (9) −0.0002 (8) 0.0085 (8) 0.0112 (7) C14 0.0435 (9) 0.0398 (9) 0.0382 (8) −0.0059 (7) 0.0068 (7) 0.0023 (7) C15 0.0369 (8) 0.0552 (10) 0.0246 (7) 0.0012 (7) 0.0062 (6) −0.0038 (7) C16 0.0458 (10) 0.0537 (11) 0.0356 (8) 0.0012 (8) 0.0108 (7) −0.0030 (7) C17 0.0557 (12) 0.0637 (13) 0.0466 (10) 0.0147 (10) 0.0110 (9) −0.0020 (9) C18 0.0450 (11) 0.0851 (16) 0.0516 (11) 0.0149 (11) 0.0121 (9) −0.0055 (11) C19 0.0423 (10) 0.0897 (17) 0.0468 (10) −0.0004 (10) 0.0174 (8) 0.0024 (10) C20 0.0451 (10) 0.0666 (12) 0.0390 (9) 0.0030 (9) 0.0134 (8) 0.0060 (8) C21 0.0455 (9) 0.0469 (10) 0.0306 (8) −0.0008 (8) 0.0114 (7) 0.0013 (7) C22 0.0468 (10) 0.0495 (10) 0.0284 (7) 0.0019 (8) 0.0095 (7) 0.0012 (7) C23 0.0478 (9) 0.0443 (9) 0.0297 (7) 0.0018 (8) 0.0128 (7) 0.0017 (7) N1 0.0366 (7) 0.0478 (8) 0.0314 (6) 0.0043 (6) 0.0103 (5) 0.0039 (6) N2 0.0430 (8) 0.0506 (8) 0.0350 (7) 0.0067 (7) 0.0169 (6) 0.0086 (6) O1 0.0382 (7) 0.0846 (10) 0.0426 (7) 0.0081 (7) 0.0006 (5) −0.0051 (7) O2 0.0499 (8) 0.0530 (8) 0.0662 (9) −0.0085 (6) 0.0217 (7) −0.0033 (7) O3 0.0656 (9) 0.0516 (8) 0.0523 (8) 0.0137 (7) 0.0225 (7) 0.0076 (6) S1 0.0334 (2) 0.0542 ( 122.0 (2) C22-N1-S1 123.83 (12) C2-C3-H3 119.0 C8-N1-S1 122.82 (11) C4-C3-H3 119.0 C15-N2-C8 120.95 (14) C5-C4-C3 119.1 (2) C15-N2-C21 123.20 (14) Hydrogen-bond geometry (Å, °) Cg2 and Cg4 are the centroids of the C2-C7 and C15-C20 rings, respectively. supplementary materials sup-10 Fig. 1 
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2-(4-Chlorophenyl)-5-(cyclohex-1-en-1-yl)-3-(4-methylphenylsulfonyl)-1-phenylimidazolidin-4-one
